TransCode (RNAZ) slips post 53% jump: A health stock to buy on the dip?

Highlights  SmileDirectClub Inc (NYSE:SDC, SDC:US) saw its stock price rocket by more than 16 per cent on Monday, September 13. Before markets opened on Tuesday, investors appeared to be showing interest in the stock as it continued to ris...

Stocks of biopharmaceutical company Kadmon Holdings (NYSE:KDMN, KDMN:US) took a significant flight as the markets opened on Wednesday, September 8. At the time of writing this, KDMN stocks were trading at a value of US$ 9.15 per piece, noting a su...

Highlights Chembio has announced that it will start the commercial distribution of its SCoV-2 Ag Detect ™ Rapid Test. CEMI stock is gaining investors’ attention as the commercial distribution is expected to expand the revenues of th...

Highlights  Digital healthcare company CloudMD (TSXV:DOC) achieved record revenues in the second quarter of 2021. In Q2 2021, CloudMD closed four acquisitions, namely that of Aspiria, Oncidium, VisionPros, and Rxi. The global digital heal...

Trillium Therapeutics Inc (TSX: TRIL) saw its stocks rise after pharmaceutical giant Pfizer Inc (NYSE: PFE) announced on Monday, August 23, that it is set to acquire the Canadian drug maker. At the time of writing this, Trillium stocks were up by ...

Biopharma firm Catabasis Pharmaceuticals Inc (NASDAQ:CATB, CATB:US) saw its stocks catapult by about 580 per cent on Friday, August 20 (9.40AM EST). The surge saw the pharma stock hit a value of US$ 8.3, up from its previous close of US$ 1.22, and...

The biotechnology stock Antibe Therapeutics (TSX:ATE) has been nosediving, with the highest drop in price by nearly 76 per cent over the past three months. On August 3, 2021, the stock closed at C$ 1.00 with a one-day trading volume of 4.31 million ...

Summary Medical students have high rates of depression and burnout. Many med students are troubled due to lack of financial support. We look at why are wellness programs are important. Popularity of wellness programs seem to have skyrocke...

The outbreak of COVID-19 has worked as a massive challenge as well as an opportunity for the pharmaceutical industry over the past year. A number of biotech and pharma companies around the world have spent significant time and funds on researching an...

Summary Stocks of EyeGate Pharmaceuticals, Inc. (EYEG:US, NASDAQ: EYEG) soared by about 103 per cent in the premarket trading hours on Tuesday, July 27. Once the markets opened, EYEG stock was recording a growth of roughly 37 per cent at the ti...